LHX three-lens brief
Evidence-based stock research on LHX. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -2.75% yesterday. · Underperforming SPY by 26.1pp over 30 days.
- Moved -2.75% yesterday.
- Underperforming SPY by 26.1pp over 30 days.
- Analyst mean target $382.53 — 27% above current (19 analysts).
- Debt-to-equity of 34.6 — balance-sheet-heavy.
LHX closed at $300.95 (-2.75%) as of 2026-05-13. Market cap: $56.07B. P/E (trailing) 32.6. Positives: analyst mean target $382.53 — 27% above current (19 analysts).. Concerns: moved -2.75% yesterday.; underperforming SPY by 26.1pp over 30 days.. Last quarter: Revenue $5.74B, net income $512.00M.
Why three lenses on LHX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine LHXacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/LHX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath LHX brief"></iframe>